Follow
James A Daniel
James A Daniel
Associate Director Antibody Discovery Neuroscience, Teva Pharmaceuticals
Verified email at mpinat.mpg.de
Title
Cited by
Cited by
Year
Building a better dynasore: the dyngo compounds potently inhibit dynamin and endocytosis
A McCluskey, JA Daniel, G Hadzic, N Chau, EL Clayton, A Mariana, ...
Traffic 14 (12), 1272-1289, 2013
3172013
A study of clustered data and approaches to its analysis
S Galbraith, JA Daniel, B Vissel
Journal of Neuroscience 30 (32), 10601-10608, 2010
2892010
Phenothiazine‐Derived Antipsychotic Drugs Inhibit Dynamin and Clathrin‐Mediated Endocytosis
JA Daniel, N Chau, MK Abdel‐Hamid, L Hu, L von Kleist, A Whiting, ...
Traffic 16 (6), 635-654, 2015
1302015
Activin A is essential for neurogenesis following neurodegeneration
A Abdipranoto‐Cowley, JS Park, D Croucher, J Daniel, S Henshall, ...
Stem Cells 27 (6), 1330-1346, 2009
962009
Iminochromene inhibitors of dynamins I and II GTPase activity and endocytosis
TA Hill, A Mariana, CP Gordon, LR Odell, MJ Robertson, AB McGeachie, ...
Journal of medicinal chemistry 53 (10), 4094-4102, 2010
652010
Analysis of synaptic vesicle endocytosis in synaptosomes by high-content screening
JA Daniel, CS Malladi, E Kettle, A McCluskey, PJ Robinson
Nature Protocols 7 (8), 1439-1455, 2012
552012
The pthaladyns: GTP competitive inhibitors of dynamin I and II GTPase derived from virtual screening
LR Odell, D Howan, CP Gordon, MJ Robertson, N Chau, A Mariana, ...
Journal of medicinal chemistry 53 (14), 5267-5280, 2010
532010
A fluorescent nanosensor paint detects dopamine release at axonal varicosities with high spatiotemporal resolution
S Elizarova, AA Chouaib, A Shaib, B Hill, F Mann, N Brose, S Kruss, ...
Proceedings of the National Academy of Sciences 119 (22), e2202842119, 2022
402022
Analysis of SUMO1-conjugation at synapses
JA Daniel, BH Cooper, JJ Palvimo, FP Zhang, N Brose, M Tirard
Elife 6, 2017
372017
Functional heterogeneity at dopamine release sites
JA Daniel, S Galbraith, L Iacovitti, A Abdipranoto, B Vissel
Journal of Neuroscience 29 (46), 14670-14680, 2009
372009
Imaging of Monoamine Neurotransmitters with Fluorescent Nanoscale Sensors.
M Dinarvand, S Elizarova, J Daniel, S Kruss
ChemPlusChem 85 (7), 1465-1480, 2020
312020
Pyrimidyn compounds: dual-action small molecule pyrimidine-based dynamin inhibitors
AB McGeachie, LR Odell, A Quan, JA Daniel, N Chau, TA Hill, ...
ACS chemical biology 8 (7), 1507-1518, 2013
282013
Pyrimidine-based inhibitors of dynamin I GTPase activity: competitive inhibition at the pleckstrin homology domain
LR Odell, MK Abdel-Hamid, TA Hill, N Chau, KA Young, FM Deane, ...
Journal of medicinal chemistry 60 (1), 349-361, 2017
192017
Response: Commentary: Analysis of SUMO1-conjugation at synapses
JA Daniel, BH Cooper, JJ Palvimo, FP Zhang, N Brose, M Tirard
Frontiers in cellular neuroscience 12, 117, 2018
142018
A fluorescent nanosensor paint reveals the heterogeneity of dopamine release from neurons at individual release sites
S Elizarova, A Chouaib, A Shaib, F Mann, N Brose, S Kruss, JA Daniel
bioRxiv, 2021
32021
Rapid Analysis of Synaptic Vesicle Endocytosis in Synaptosomes
JA Daniel, PJ Robinson
Exocytosis Methods, 167-189, 2014
22014
The Sulfonadyns: a class of aryl sulfonamides inhibiting dynamin I GTPase and clathrin mediated endocytosis are anti-seizure in animal models
LR Odell, NC Jones, N Chau, MJ Robertson, JI Ambrus, FM Deane, ...
RSC Medicinal Chemistry, 2023
12023
An intellectual-disability-associated mutation of the transcriptional regulator NAC1 impairs glutamatergic neurotransmission
JA Daniel, S Elizarova, A Shaib, A Chouaib, HM Magnussen, J Wang, ...
Frontiers in Molecular Neuroscience 16, 1115880, 0
1
Studies of neurotransmitter release mechanisms in dopamine neurons
J Daniel
UNSW Sydney, 2007
2007
The system can't perform the operation now. Try again later.
Articles 1–19